HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

REMSleep Holdings, Inc. (OTCQB: RMSL), a developer of the FDA-cleared DeltaWave(TM) nasal pillow system, today announced that it has received Healthcare Common Procedure Coding System (HCPCS) ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

KELOWNA, BC, Jan. 29, 2026 /CNW/ – Cantex Mine Development Corp. (TSXV: CD) (OTCQB: CTXDF) (the “Company”) is pleased to ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Detailed price information for Americas Gold and Silver Corp (USAS-A) from The Globe and Mail including charting and trades.

Credit: Getty Images The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease. Test your ...

Bacteria incubated with bacteriophages in space accumulated distinct mutations compared to those on Earth, highlighting the ...

"Lower dose does not mean lower responsibility." ...

The "Viva Voce" (oral exam) remains a source of anxiety for many. Schools are conducting mock viva sessions to help students ...